Cella D - Search Results

1

Trask PC, Cella D, Besson N, Kelly V, Masszi T, Kim DW. Trask PC, et al. Among authors: cella d. Leuk Res. 2012 Apr;36(4):438-42. doi: 10.1016/j.leukres.2011.10.011. Epub 2011 Oct 28. Leuk Res. 2012. PMID: 22036634 Clinical Trial.

2

A patient-based utility measure of health for clinical trials of cancer therapy based on the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire.

Pickard AS, Shaw JW, Lin HW, Trask PC, Aaronson N, Lee TA, Cella D. Pickard AS, et al. Among authors: cella d. Value Health. 2009 Sep;12(6):977-88. doi: 10.1111/j.1524-4733.2009.00545.x. Epub 2009 Apr 23. Value Health. 2009. PMID: 19402850 Free article.

3

Health-related quality of life in chronic myeloid leukemia.

Trask PC, Cella D, Powell C, Reisman A, Whiteley J, Kelly V. Trask PC, et al. Among authors: cella d. Leuk Res. 2013 Jan;37(1):9-13. doi: 10.1016/j.leukres.2012.09.013. Epub 2012 Oct 29. Leuk Res. 2013. PMID: 23116602

4

Whiteley J, Reisman A, Shapiro M, Cortes J, Cella D. Whiteley J, et al. Among authors: cella d. Curr Med Res Opin. 2016 Aug;32(8):1325-34. doi: 10.1185/03007995.2016.1174108. Epub 2016 May 5. Curr Med Res Opin. 2016. PMID: 27045164

5

The impact of tofacitinib on fatigue, sleep, and health-related quality of life in patients with rheumatoid arthritis: a post hoc analysis of data from Phase 3 trials.

Bartlett SJ, Bingham CO, van Vollenhoven R, Murray C, Gruben D, Gold DA, Cella D. Bartlett SJ, et al. Among authors: cella d. Arthritis Res Ther. 2022 Apr 5;24(1):83. doi: 10.1186/s13075-022-02724-x. Arthritis Res Ther. 2022. PMID: 35382883 Free PMC article. Clinical Trial.

6

Quality of life in patients with newly diagnosed chronic phase chronic myeloid leukemia on imatinib versus interferon alfa plus low-dose cytarabine: results from the IRIS Study.

Hahn EA, Glendenning GA, Sorensen MV, Hudgens SA, Druker BJ, Guilhot F, Larson RA, O'Brien SG, Dobrez DG, Hensley ML, Cella D; IRIS Investigators. Hahn EA, et al. Among authors: cella d. J Clin Oncol. 2003 Jun 1;21(11):2138-46. doi: 10.1200/JCO.2003.12.154. J Clin Oncol. 2003. PMID: 12775739 Clinical Trial.

7

Robinson DW Jr, Cormier JN, Zhao N, Uhlar CM, Revicki DA, Cella D. Robinson DW Jr, et al. Among authors: cella d. Melanoma Res. 2012 Feb;22(1):54-62. doi: 10.1097/CMR.0b013e32834d3da0. Melanoma Res. 2012. PMID: 22027908 Clinical Trial.

8

The impact of symptom burden on patient quality of life in chronic myeloid leukemia.

Cella D, Nowinski CJ, Frankfurt O. Cella D, et al. Oncology. 2014;87(3):133-47. doi: 10.1159/000362816. Epub 2014 Jul 8. Oncology. 2014. PMID: 25012261 Review.

9

Important Group Differences on the Functional Assessment of Cancer Therapy-Kidney Symptom Index Disease-Related Symptoms in Patients with Metastatic Renal Cell Carcinoma.

Cella D, Motzer RJ, Rini BI, Cappelleri JC, Ramaswamy K, Hariharan S, Arondekar B, Bushmakin AG. Cella D, et al. Value Health. 2018 Dec;21(12):1413-1418. doi: 10.1016/j.jval.2018.04.1371. Epub 2018 May 11. Value Health. 2018. PMID: 30502785 Free PMC article. Clinical Trial.

10

Quality of life predicts progression-free survival in patients with metastatic renal cell carcinoma treated with sunitinib versus interferon alfa.

Cella D, Cappelleri JC, Bushmakin A, Charbonneau C, Li JZ, Kim ST, Chen I, Michaelson MD, Motzer RJ. Cella D, et al. J Oncol Pract. 2009 Mar;5(2):66-70. doi: 10.1200/JOP.0922004. J Oncol Pract. 2009. PMID: 20856722 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,173 results

Search Page